Dr. William J Edenfield, MD
Claim this profilePrisma Health
Studies Cancer
Studies Solid Tumors
13 reported clinical trials
18 drugs studied
Area of expertise
1Cancer
Stage IV
TSC1 positive
TSC2 positive
2Solid Tumors
Stage IV
Stage III
TSC1 positive
Affiliated Hospitals
Clinical Trials William J Edenfield, MD is currently running
SHR-A1904
for Advanced Cancer
This trial is testing a new drug called SHR-A1904 to see if it is safe and effective for people with advanced solid tumors. The study will determine the best dose to use and check how the drug moves through the body. Researchers also want to know if the drug helps fight cancer without causing harmful side effects.
Recruiting1 award Phase 1 & 2
X-PACT
for Advanced Cancers
In this Phase I trial for subjects with advanced head \& neck cancer, breast cancer, soft tissue sarcoma or melanoma all subjects will receive open label X-PACT treatment as a intra-tumoral injection. The primary objective will be to establish the safety of X-PACT when dosed with 5 intra-tumoral injections of the combination product (the phosphor device and methoxsalen sterile solution and subsequently exposing the tumor to X-ray energy) over a period of 6 weeks (on day D1, D3 and D5 of Week 1, on D1 of Week 2, and a booster on D1 of Week 6). After the week 8 tumor assessment subjects demonstrating stable disease, partial response or unconfirmed progression assessed by iRecist, will be eligible to receive two additional booster treatments 4-6 weeks apart. Treatment will be considered safe provided ≤ 2 out of 12 patients experience a dose-limiting toxicity (DLT) during the 6 weeks after the first intra-tumoral injection.
Recruiting1 award Phase 120 criteria
More about William J Edenfield, MD
Clinical Trial Related2 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments William J Edenfield, MD has experience with
- Nivolumab
- Durvalumab And Tremelimumab
- SHR-A1904
- Afuresertib
- Prednisone
- LAE001
Breakdown of trials William J Edenfield, MD has run
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William J Edenfield, MD specialize in?
William J Edenfield, MD focuses on Cancer and Solid Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are TSC1 positive.
Is William J Edenfield, MD currently recruiting for clinical trials?
Yes, William J Edenfield, MD is currently recruiting for 5 clinical trials in Greenville South Carolina. If you're interested in participating, you should apply.
Are there any treatments that William J Edenfield, MD has studied deeply?
Yes, William J Edenfield, MD has studied treatments such as Nivolumab, Durvalumab and Tremelimumab, SHR-A1904.
What is the best way to schedule an appointment with William J Edenfield, MD?
Apply for one of the trials that William J Edenfield, MD is conducting.
What is the office address of William J Edenfield, MD?
The office of William J Edenfield, MD is located at: Prisma Health, Greenville, South Carolina 29605 United States. This is the address for their practice at the Prisma Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.